WuXi AppTec highlighted the strength of its integrated CRDMO model and growing exposure to late-stage and commercial assets as key drivers of sustained growth, Dr Minzhang Chen, co-CEO, said at the 44th Annual JP Morgan Healthcare Conference on 14 January 2026. Presenting at the conference, Dr Chen pointed to strong preliminary 2025 results, with revenue reaching 45.5bn yuan, up 21.4% year-on-year from continuing operations. Adjusted non-IFRS net profit reached 15bn yuan, resulting in a net profit margin ...